Open access
Open access
Powered by Google Translator Translator

Study: Assessment of the Clinical Benefit of Cancer Drugs Receiving Accelerated Approval

29 May, 2019 | 02:00h | UTC

Assessment of the Clinical Benefit of Cancer Drugs Receiving Accelerated Approval – JAMA Internal Medicine (free for a limited period)

Related Study: An Overview of Cancer Drugs Approved by the US Food and Drug Administration Based on the Surrogate End Point of Response Rate – JAMA Internal Medicine (free for a limited period)

Invited Commentaries: An International Perspective on Drugs for Cancer: The Best of Times, the Worst of Times (free for a limited period) AND Accelerated Approval of Cancer Drugs—Righting the Ship of the US Food and Drug Administration (free for a limited period)

Commentaries: Cancer Drugs Approved Quickly Often Fail To Measure Up Later – NPR (free) AND Questions raised over cancer drugs in FDA’s accelerated approval program – CNN (free)

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.